CD4 and influenza: This finding provides an argument for vaccination strategies that promote broadly cross reactive HA-specific CD4 T cell immunity, which could enable robust antibody production in response to viruses or vaccines composed of novel and potentially pandemic influenza strains against which the host has few preexisting neutralizing antibodies.